- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Mainz Biomed is a diagnostics & research business based in the US. Mainz Biomed shares (MYNZ) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $6.68 – an increase of 24.63% over the previous week. Mainz Biomed employs 65 staff and has a trailing 12-month revenue of around $917,203.
Our top picks for where to buy Mainz Biomed BV stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
How to buy Mainz Biomed stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – MYNZ. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Mainz Biomed stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Mainz Biomed stock price (NASDAQ: MYNZ)
Use our graph to track the performance of MYNZ stocks over time.Mainz Biomed shares at a glance
Latest market close | $6.68 |
---|---|
52-week range | $0.18 - $7.95 |
50-day moving average | $1.52 |
200-day moving average | $0.83 |
Wall St. target price | $2.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-44.40 |
Is it a good time to buy Mainz Biomed stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Mainz Biomed price performance over time
Historical closes compared with the close of $4.77 from 2024-12-19
1 week (2024-12-13) | -11.01% |
---|---|
1 month (2024-11-21) | 2,145.76% |
3 months (2024-09-20) | 78,096.72% |
6 months (2024-06-21) | 42,489.29% |
1 year (2023-12-21) | 16,069.49% |
---|---|
2 years (2022-12-21) | -36.99% |
3 years (2021-12-21) | 9.21 |
5 years (2019-12-17) | N/A |
Mainz Biomed financials
Revenue TTM | $917,203 |
---|---|
Gross profit TTM | $177,622 |
Return on assets TTM | -99.24% |
Return on equity TTM | -4333.71% |
Profit margin | 0% |
Book value | $-0.16 |
Market Capitalization | $8.4 million |
TTM: trailing 12 months
Mainz Biomed share dividends
We're not expecting Mainz Biomed to pay a dividend over the next 12 months.
You may also wish to consider:
- Pfizer (PFE.US) (6.64% forward annual dividend yield)
- AstraZeneca PLC ADR (AZN.US) (2.3% forward annual dividend yield)
Have Mainz Biomed's shares ever split?
Mainz Biomed's shares were split on a 1:40 basis on 2 December 2024 . So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Mainz Biomed shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Mainz Biomed shares which in turn could have impacted Mainz Biomed's share price.
Mainz Biomed share price volatility
Over the last 12 months, Mainz Biomed's shares have ranged in value from as little as $0.1791 up to $7.95. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mainz Biomed's is 0.076. This would suggest that Mainz Biomed's shares are less volatile than average (for this exchange).
To put Mainz Biomed's beta into context you can compare it against those of similar companies.
- Moderna (MRNA.US): 1.69
- Pfizer (PFE.US): 0.615
- AstraZeneca PLC ADR (AZN.US): 0.18
Mainz Biomed overview
Mainz Biomed N. V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. It has a collaboration agreement with Thermo Fisher Scientific Inc. for the development of colorectal cancer screening product.
Frequently asked questions
What percentage of Mainz Biomed is owned by insiders or institutions?Currently 4.98% of Mainz Biomed shares are held by insiders and 0.217% by institutions. How many people work for Mainz Biomed?
Latest data suggests 65 work at Mainz Biomed. When does the fiscal year end for Mainz Biomed?
Mainz Biomed's fiscal year ends in December. Where is Mainz Biomed based?
Mainz Biomed's address is: Robert Koch Strasse 50, Mainz, Germany, 55129 What is Mainz Biomed's ISIN number?
Mainz Biomed's international securities identification number is: NL0015000LC2
More guides on Finder
-
How to buy Merck-and-Company stock (MRK)
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Intuitive Surgical stock (ISRG)
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
-
How to buy Vertex Pharmaceuticals stock (VRTX)
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
-
How to buy McKesson Corporation stock (MCK)
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Amgen stock (AMGN)
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
-
How to buy Abbott Laboratories stock (ABT)
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question